logo

For the Inventor, By the Inventor

Harleysville, PA, United States of America

Timothy Francis Gallagher

This inventor holds 51 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Smithkline Beecham Corporation, Merck + Co., Inc., Aventis Pharmaceuticals Inc.. Active years: 1985-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Francis Gallagher. Retrieved from https://idiyas.com/inventor/timothy-francis-gallagher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51 

% Patents Active = 80.4


Average Co-Inventor Count = 4.2

ph-index = 19

Forward Citations = 1,143(Granted Patents)

Forward Citations (Not Self Cited) = 1,122(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Metuchen, NJ (US) (1985 - 1988)
  • Harlesyville, PA (US) (2000)
  • Harleysville, PA (US) (1987 - 2009)
  • Collegeville, PA (US) (2005 - 2011)

Company Filing History:

goldMedal39 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal7 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal2 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 2 out of 1,169 
 
Glaxo Group Limited
 patents
5. 1 out of 358 
 
Glaxosmithkline LLC
 patents

Years Active: 1985-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
Anthranilamide
Aurora Kinase
Antibacterial
Sulfonamides
Pyrazole
Imidazole
Pyrimidine
Cytokine Inhibitors
Protease Inhibitors
Pharmaceutical Compositions
Oligonucleotides
Drug Binding Proteins
51 patents (USPTO):Explore Patents
1. 7884098 - Anthranilamide inhibitors of aurora kinase (2011-02-08),
2. 7622481 - Antibacterial compounds (2009-11-24),
3. 7618959 - Antibacterial agents (2009-11-17),
4. 7612075 - Substituted oxoazaheterocyclyl compounds (2009-11-03),
5. 7498326 - Compounds (2009-03-03),
6. 7091204 - Sulfonamides (2006-08-15),
7. 7026349 - Sulfonamides (2006-04-11),
8. 6849635 - Sulfonamides (2005-02-01),
9. 6774127 - Pyrazole and pyrazoline substituted compounds (2004-08-10),
10. 6730683 - Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses (2004-05-04),
11. 6645989 - Compounds (2003-11-11),
12. 6562832 - Substituted imidazole compounds (2003-05-13),
13. 6541505 - Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds (2003-04-01),
14. 6528512 - Pyrimidine compounds useful in treating cytokine mediated diseases (2003-03-04),
15. 6369068 - Amino substituted pyrimidine containing compounds (2002-04-09),

Title: Timothy Francis Gallagher: Pioneering Inventor from Harleysville

Introduction: Timothy Francis Gallagher is a distinguished inventor hailing from Harleysville, Pennsylvania. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: Gallagher's latest patents include groundbreaking inventions in the realm of renewable energy, sustainable agriculture, and advanced robotics. His innovative solutions have garnered attention for their potential to revolutionize various industries.

Career Highlights: Throughout his career, Timothy Francis Gallagher has been recognized for his inventive spirit and dedication to creating cutting-edge technologies. His work has not only earned him numerous patents but has also positioned him as a thought leader in the innovation community.

Collaborations: Gallagher has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has resulted in the successful development of groundbreaking products and solutions.

Conclusion: In conclusion, Timothy Francis Gallagher stands as a testament to the power of innovation and perseverance. His contributions to the world of inventions have left a lasting impact, inspiring future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…